Jump to content

Search the hub

Showing results for tags 'Antimicrobial resistance (AMR)'.


More search options

  • Search By Tags

    Start to type the tag you want to use, then select from the list.

  • Search By Author

Content Type


Forums

  • All
    • Commissioning, service provision and innovation in health and care
    • Coronavirus (COVID-19)
    • Culture
    • Improving patient safety
    • Investigations, risk management and legal issues
    • Leadership for patient safety
    • Organisations linked to patient safety (UK and beyond)
    • Patient engagement
    • Patient safety in health and care
    • Patient Safety Learning
    • Professionalising patient safety
    • Research, data and insight
    • Miscellaneous

Categories

  • Commissioning, service provision and innovation in health and care
    • Commissioning and funding patient safety
    • Digital health and care service provision
    • Health records and plans
    • Innovation programmes in health and care
    • Climate change/sustainability
  • Coronavirus (COVID-19)
    • Blogs
    • Data, research and statistics
    • Frontline insights during the pandemic
    • Good practice and useful resources
    • Guidance
    • Mental health
    • Exit strategies
    • Patient recovery
    • Questions around Government governance
  • Culture
    • Bullying and fear
    • Good practice
    • Occupational health and safety
    • Safety culture programmes
    • Second victim
    • Speak Up Guardians
    • Staff safety
    • Whistle blowing
  • Improving patient safety
    • Clinical governance and audits
    • Design for safety
    • Disasters averted/near misses
    • Equipment and facilities
    • Error traps
    • Health inequalities
    • Human factors (improving human performance in care delivery)
    • Improving systems of care
    • Implementation of improvements
    • International development and humanitarian
    • Patient Safety Alerts
    • Safety stories
    • Stories from the front line
    • Workforce and resources
  • Investigations, risk management and legal issues
    • Investigations and complaints
    • Risk management and legal issues
  • Leadership for patient safety
    • Business case for patient safety
    • Boards
    • Clinical leadership
    • Exec teams
    • Inquiries
    • International reports
    • National/Governmental
    • Patient Safety Commissioner
    • Quality and safety reports
    • Techniques
    • Other
  • Organisations linked to patient safety (UK and beyond)
    • Government and ALB direction and guidance
    • International patient safety
    • Regulators and their regulations
  • Patient engagement
    • Consent and privacy
    • Harmed care patient pathways/post-incident pathways
    • How to engage for patient safety
    • Keeping patients safe
    • Patient-centred care
    • Patient Safety Partners
    • Patient stories
  • Patient safety in health and care
    • Care settings
    • Conditions
    • Diagnosis
    • High risk areas
    • Learning disabilities
    • Medication
    • Mental health
    • Men's health
    • Patient management
    • Social care
    • Transitions of care
    • Women's health
  • Patient Safety Learning
    • Patient Safety Learning campaigns
    • Patient Safety Learning documents
    • Patient Safety Standards
    • 2-minute Tuesdays
    • Patient Safety Learning Annual Conference 2019
    • Patient Safety Learning Annual Conference 2018
    • Patient Safety Learning Awards 2019
    • Patient Safety Learning Interviews
    • Patient Safety Learning webinars
  • Professionalising patient safety
    • Accreditation for patient safety
    • Competency framework
    • Medical students
    • Patient safety standards
    • Training & education
  • Research, data and insight
    • Data and insight
    • Research
  • Miscellaneous

News

  • News

Find results in...

Find results that contain...


Date Created

  • Start
    End

Last updated

  • Start
    End

Filter by number of...

Joined

  • Start

    End


Group


First name


Last name


Country


About me


Organisation


Role

Found 84 results
  1. News Article
    New cases of the sexually transmitted infection syphilis have risen again in England, continuing a trend dating back to the early 2000s. While the overall number of people diagnosed with gonorrhoea has fallen, there has been a significant increase in the number of cases where the infection is drug resistant, new UK Health Security Agency (UKHSA) data, external shows. Health experts say this is a real concern, although the actual number of drug-resistant cases remains very low. The NHS recently announced the rollout of the world's first vaccine programme to protect against gonorrhoea, aimed principally at gay and bisexual men. The World Health Organisation describes antimicrobial resistance as an issue of global concern and one of the biggest threats to global health. It threatens our ability to treat common infections and to perform life-saving procedures, including chemotherapy for cancer, caesarean sections, hip replacements, organ transplants and other operations. Read full story Source: BBC News, 3 June 2025
  2. Content Article
    In February the HSCIT hosted a webinar for adult social care services about what we can all do to keep antibiotics working. The webinar aimed to raise awareness of antimicrobial resistance and antimicrobial stewardship across adult social care and to explore what they mean in practice. The webinar featured presentations from two antimicrobial stewardship nurses and a principal educator from NHS Education for Scotland, as well as a question and answer session.
  3. News Article
    Pharmacists are facing inappropriate demands for antibiotics every day, with some patients stockpiling them for holidays despite the threat posed by antimicrobial resistance, a report says. Staff receive requests for the drugs to treat minor ailments such as coughs and colds even if they are not needed, according to the National Pharmacy Association (NPA), which represents 6,000 independent community pharmacies in England. Its survey found 79% of pharmacists were having to refuse requests for antibiotics from patients at least once a day. A quarter of pharmacists said patients frequently returned partially used antibiotics, while 37% were aware of patients regularly hoarding them for a later date. Half-used courses of antibiotics were being posted on local social media groups, the NPA said. Other issues include patients requesting antibiotics from their pharmacy before going on holiday just in case of illness, and people returning from abroad with huge quantities of antibiotics for conditions not treated by them in the UK. Olivier Picard, the chair of the NPA, said: “These are concerning findings and shows there are widespread misconceptions about the role that antibiotics can play among some patients. “Although antibiotics may be an appropriate course of treatment for some conditions, for other ailments like viral coughs and sore throats, they may not be effective. This could also mean antibiotics may not be effective for treating more serious conditions, posing a risk to patient safety." Read full story Source: The Guardian, 6 May 2025 Related reading on the hub: Top picks: Key resources on antimicrobial resistance
  4. News Article
    Less than 7% of people with severe drug-resistant infections in poorer countries get the antibiotics they need, a new study suggests, with researchers warning that not only is this causing suffering and deaths, but is also likely to be driving antimicrobial resistance (AMR). With AMR forecast to cause 1.9m deaths a year by 2050, they are calling for urgent action, akin to the fight earlier this century to get HIV drugs to Africa’s virus hotspots. “The stark reality is that most people with highly drug-resistant infections are not getting access to the antibiotics they need,” said Dr Jennifer Cohn, a senior author of the study. AMR is a process whereby bacteria and other pathogens evolve resistance to treatments typically used against them. One driver is the overuse of antibiotics, with greater exposure to drugs offering bacteria more chances to learn how to evade them. But a focus on overuse has meant access has been neglected, the experts warn. Read full story Source: The Guardian, 30 April 2025
  5. Content Article
    Antimicrobial resistance (AMR) a critical global health threat that undermines the safety of routine medical procedures and reverses many advancements in modern medicine by making antimicrobials ineffective to treat infections. Inappropriate use of antimicrobials is a major driver of AMR. This Global Antimicrobial Resistance and Use Surveillance System (GLASS) report describes global progress in antimicrobial use surveillance and antibiotic use in 2022, reported by 60 countries.
  6. Content Article
    Effectively tackling the challenge of antimicrobial resistance (AMR) requires a co-ordinated and strategic approach across healthcare settings. Antimicrobial stewardship (AMS) is an important element of this work. This publication outlines the functionalities that clinical digital systems need to support optimal antimicrobial stewardship (AMS) in primary and secondary care. It should be read alongside the Digital framework for antimicrobial stewardship – what good looks like, which sets out an organisational and system approach to ensuring good digital functionality for antimicrobial stewardship.
  7. News Article
    More than three million children around the world are thought to have died in 2022 as a result of infections that are resistant to antibiotics, according to a study by two leading experts in child health. Children in Africa and South East Asia were found to be most at risk. Antimicrobial resistance - known as AMR - develops when the microbes that cause infections evolve in such a way that antibiotic drugs no longer work. It has been identified as one of the biggest public health threats facing the world's population. A new study now reveals the toll that AMR is taking on children. Using data from multiple sources, including the World Health Organization (WHO) and the World Bank, the report's authors have calculated there were more than three million child deaths in 2022 linked to drug-resistant infections. Experts say this new study highlights a more than tenfold increase in AMR-related infections in children in just three years. Read full story Source: BBC News, 13 April 2025
  8. News Article
    Health officials in England are raising concerns about a surge in antibiotic-resistant gonorrhoea cases, warning that the sexually transmitted infection could become “untreatable” if the trend continues. Some infections have shown resistance to ceftriaxone, the primary antibiotic used. More alarmingly, some cases are classified as "extensively drug resistant" (XDR), meaning they don't respond to ceftriaxone or the secondary treatment. New data from the UK Health Security Agency (UKHSA) reveals a concerning increase in resistant cases. Between January 2024 and March 2025, 17 cases of ceftriaxone-resistant gonorrhoea were reported, 13 in 2024 and four in the first three months of 2025. Dr Katy Sinka, consultant epidemiologist and head of the STI section at UKHSA, said: “Gonorrhoea is becoming increasingly resistant to antibiotics, which could make it untreatable in future. “If left untreated, it can cause serious problems like pelvic inflammatory disease and infertility.” Read full story Source: The Independent, 27 March 2025
  9. Content Article
    This US cohort study aimed to explore how antimicrobial resistance (AMR) has changed between 2012 and 2022. The findings showed that overall resistant cases per 10,000 hospitalizations declined between 2012 to 2016. However, progress varied across pathogens and was inconsistent before the Covid-19 pandemic. The pandemic was associated with notable increases in hospital-onset cases of AMR.
  10. Content Article
    Infections acquired in health care settings, including those antimicrobial resistant, cause tremendous suffering to patients, families and health workers and pose a high burden on health systems. Most of these infections are preventable with appropriate infection prevention and control (IPC) programmes and practices and basic water, sanitation and hygiene (WASH) services. Improving IPC and WASH saves lives and yields high economic gains. At the 77th World Health Assembly, all countries adopted the WHO global action plan and monitoring framework 2024-2030. This document provides the evidence on the expected return in investment in and guidance for implementing and monitoring the WHO global action plan on IPC at the country level.
  11. Content Article
    For some years, the World Health Organization and other international bodies have urged countries to take wide-ranging measures to reduce the spread of AMR. In the UK, such action involves multiple public bodies including the Department for Health & Social Care (DHSC), the Department for Environment, Food & Rural Affairs (Defra), where AMR policy is led by the Veterinary Medicines Directorate (VMD), and the devolved administrations of Northern Ireland, Scotland and Wales. These and other public bodies have been coordinating their activities using five-year national action plans. The National Audit Office are investigating the government’s response to AMR because it is a serious public health threat, and because the UK’s experiences during the COVID-19 pandemic showed the country was not as resilient to such threats as it expected to be. This report sets out information on the risk posed by AMR and the UK government’s response. It focuses on the response in England, where the UK government has responsibility for the NHS and key aspects of animal health and environmental policy.
  12. News Article
    Superbugs are on the rise in the UK and the government is failing in its efforts to tackle them, ministers have been warned. The World Health Organization has described antimicrobial resistance (AMR) – where pathogens evolve and develop resistance to antibiotics and other antimicrobials so the drugs usually used to fight them no longer work – as “one of the top global public health and development threats”. AMR is already contributing to more than 35,000 deaths a year in the UK, estimates suggest. But the government “remains a long way” from achieving its aim of containing and controlling AMR, the National Audit Office (NAO) said. If urgent action is not taken to stem the crisis, the consequences for health, life expectancy, the functioning of the NHS and the wider economy would be “huge”, the watchdog said. Read full story Source: The Guardian, 26 February 2025
  13. Content Article
    NHSN is a secure, web-based surveillance application that is the nation’s most widely used healthcare-associated infection (HAI) tracking system. The application is managed and maintained by the Division of Healthcare Quality Promotion (DHQP) at the Centers for Disease Control and Prevention (CDC). While ensuring data security, integrity, and confidentiality, NHSN gives healthcare facilities the ability to see their data in real-time and share that information with clinicians and facility leadership, as well as with other facilities (e.g., a multihospital system) and partners such as health departments or quality improvement organizations. CDC provides the standard national measures for HAIs as well as analytic tools that enable each facility to assess its progress and identify where additional efforts are needed. In addition, NHSN is the conduit for facilities to comply with Centers for Medicare and Medicaid Services (CMS) infection reporting requirements. NHSN provides medical facilities, states, regions, and the nation with data collection and reporting capabilities needed to: identify infection prevention problems by facility, state, or specific quality improvement project benchmark progress of infection prevention efforts comply with state and federal public reporting mandates drive national progress toward elimination of HAIs. NHSN includes the following components: Patient Safety, Long-term Care Facility, Outpatient Dialysis, Healthcare Personnel Safety, Biovigilance, Outpatient Procedure, and Neonatal.
  14. Content Article
    Ron Daniels is a Consultant in Critical Care, Vice President of the Global Sepsis Alliance, Chief Medical Officer of the United Kingdom Sepsis Trust, and a Topic leader for Patient Safety Learning’s hub.  In this interview, Ron explains why doctors have to carefully manage the use of antibiotics in order to protect patients, now and in the future.  What’s the issue with prescribing antibiotics? For decades we have been using antibiotics to treat and reduce infection, and to stop people dying from infection. Unfortunately, some of the bacteria (and related organisms) we’ve been fighting have become resistant to certain types of antibiotics (or antimicrobials, in the case of other germs such as viruses, parasites and fungi). This is also known as antimicrobial resistance (AMR). Lots of people wrongly think that a patient can become resistant to antibiotics. It’s the bug, not the person. Prescribing antibiotics unnecessarily leads to more and more bugs becoming resistant, leaving patients with fewer treatment options. This is already having a huge impact on healthcare as we know it, with thousands of people affected. We need to manage the risks now, and as we move forward into the future. What does this mean for patients? If you become poorly with a bug that is resistant to a type of antibiotic, prescribing that antibiotic to you will not make you better. Your symptoms will remain or get worse. As you can imagine, this makes those particular bugs very difficult to treat, and serious life-threatening infections like sepsis more likely to occur. Worryingly, statistics indicate that patients in more deprived areas are more likely to be affected. If a doctor is concerned that you are unwell with a bug that cannot be treated with the usual ‘first choice’ course of antibiotics, they may change it or prescribe something called a ‘broad spectrum antibiotic’ to help you feel better. In some circumstances, this is lifesaving. Unfortunately using these ‘broad spectrum antibiotics’ can lead to even more bugs becoming resistant to even more types of antibiotics. There also tends to be more side effects for the patient. What are the big risks? There are a number of risks and challenges that have to be really carefully managed around the use of antibiotics. Essentially, we want to make sure: Standard and broad-spectrum antibiotics are not being prescribed unnecessarily and contributing to the issue of an increasing number of bugs being resistant to our treatments. Patients get the antibiotics they need and do not become seriously unwell or at risk of sepsis. Health inequalities do not widen. How do doctors know what to do for the best? Deciding whether or not to give antibiotics to a patient, and which type is best if you do, can be very difficult. There are tests that can identify what type of bug a patient has and what it is resistant to. There are other tests – called biomarkers – which can help with the decision as to whether or not antibiotics are needed at all. These tests can really help healthcare professionals make decisions around antibiotics, but these services are not yet widely available. What do you hope to see in future? We need to help the public understand these issues and how they are affecting healthcare and decision-making. Many people visiting their doctor will strongly believe that antibiotics are the solution to their problem. There can be a lot of pressure to prescribe them, and it can be hard to explain why that’s not always the best approach. If someone looks very sick, their GP will be sending them straight to hospital. But if not, having access to a biomarker test in the community would help people feel reassured and support that important doctor-patient relationship, especially when antibiotics are not being prescribed. Doctors need to be empowered to make the best and safest decisions for their patients. I believe we should be piloting having biomarker testing within close access to GP surgeries. For those patients deemed in need of antibiotics, further tests should guide the choice of medicine. That way, patients could quickly and easily be offered testing, and the rapid results would help their doctor decide whether to prescribe antibiotics and if so, which type would be most effective. Focusing the pilots in urban areas where there is significant variation in wealth would also help us understand and manage the risk of widening health inequalities. These actions could help reduce unnecessary antibiotic use and protect patients from serious infection. Ultimately, helping to limit the threat to human life both now and in the future. Related content Top picks: 14 key resources on antimicrobial resistance Tackling antibiotic underdosing: Interview with Ruth Dando, Head of Nursing for Theatres, Critical Care and Anaesthetics at BHRUHT What factors in the workplace enable success in antimicrobial stewardship in paediatric intensive care? Tackling antimicrobial resistance: How to keep antibiotics working for the next century Antimicrobial resistance survivors: calling the world to action Patient capacity building for advocacy and research: The case of the European Patient Group on Antimicrobial Resistance Department of Health and Social Care: Confronting antimicrobial resistance 2024 to 2029
  15. Content Article
    This report provides an overview of keynote speeches and panel sessions at the third annual Safety For All Conference at the Royal College of Physicians in London on Tuesday 10 December 2024 The Safety For All campaign is focused on driving improvements in and between healthcare worker safety and patient safety. It seeks to highlight how poor staff safety standards and practice impact adversely on patient safety, and vice versa. The campaign champions the need for a systematic and integrated approach to improve safety for staff and patients across health and social care. Safety For All is jointly coordinated by the Safer Healthcare and Biosafety Network and Patient Safety Learning, supported by Boston Scientific and Stryker. The event was chaired by Professor Rob Galloway, Accident and Emergency Consultant at the University Hospitals Sussex NHS Trust. It was attended by over 100 members of the healthcare community, including occupational health professionals, patient safety experts, frontline staff, patients and academics. The report includes summaries of the conference’s speeches by: Professor Nicola Ranger, Chief Executive of the Royal College of Nursing Jane Murkin, Deputy Director Safety and Improvement – Nursing Directorate at NHS England. It also provides an overview of the following panel sessions across the day: Protecting lives while protecting the planet. Navigating the many faces of violence in healthcare. Caring for caregivers and patients – Mental health and safety in healthcare. Antimicrobial Resistance – Ensuring patient safety in an era of rising resistance. Implementing the Patient Safety Incident Response Framework. Throughout the speeches and panel discussions that ran across the day, there were several recurring themes: The important role of leadership in improving staff safety and patient safety. This being cited as the key to creating safer organisational cultures, modelling safety behaviours and advocating on behalf of patients and staff. The need for healthcare workers and patients to speak up in order to create a safer healthcare system, and the challenges of empowering staff to do this and organisations to create safety cultures in a system under significant strain. Communication and engagement is key – with staff and patients, and in convening people so they can collaborate for safety. Listening was mentioned throughout as being seen as a luxury, but it is essential to providing person-centred care. The challenge of sharing and spreading patient and staff safety initiatives when healthcare workers don't have time/capacity beyond trying to do the day job.
  16. News Article
    New research from the Centres for Antimicrobial Optimisation Network (CAMO-Net) at the University of Liverpool has shown that using artificial intelligence (AI) can improve how we treat urinary tract infections (UTIs), and help to address antimicrobial resistance (AMR). AMR occurs when bacteria, viruses, fungi, and parasites evolve and no longer respond to treatments that were once effective. This resistance leads to longer hospital stays, higher medical costs, and increased mortality rates, posing a significant threat to public health and potentially rendering common infections untreatable. Traditional UTI diagnostic tests, known as antimicrobial susceptibility testing (AST), uses a one-size-fits-all approach to determine which antibiotics are most effective against a specific bacterial or fungal infection. This new research, published in Nature Communications, proposes a personalised method, using real-time data to help clinicians target infections more accurately and reduce the chance of bacteria becoming resistant to antibiotic treatment. The research, led by Dr Alex Howard, a consultant in medical microbiology at the University of Liverpool and researcher on the Wellcome Trust funded CAMO-Net, used AI to test prediction models for 12 antibiotics using real patient data and compared personalised AST with standard methods. The data-driven personalised approach led to more accurate treatment options, especially with WHO Access antibiotics, known for being less likely to cause resistance. Dr Alex Howard, said: "This research is important and timely for World AMR Awareness Week because it shows how combining routine health data with lab tests can help keep antibiotics working. By using AI to predict when people with urine infections have antibiotic-resistant bugs, we show how lab tests can better direct their antibiotic treatment. This approach could improve the care of people with infections worldwide and help prevent the spread of antibiotic resistance." Read full story Source: Digital Health News, 25 November 2024
  17. Content Article
    This report highlights the burden of health care-associated infections (HAIs) and antimicrobial resistance (AMR) and the related harm to both patients and health workers in care settings. It also presents an updated global situation analysis of the implementation of infection prevention and control (IPC) programmes at the national and health care facility levels, including a focus on the WHO regions. Headline points from this report include: On average, out of every 100 patients in acute care hospitals, seven patients in high-income countries (HICs), and 15 patients in low and middle-income countries (LMICs), will acquire at least one HAI during their hospital stay. Almost up to one third (30%) of patients in intensive care can be affected by HAIs, with an incidence that is two to 20 times higher in LMICs than in HICs, in particular among neonates. One in four (23.6%) of all hospital-treated sepsis cases are health care-associated and this increases to almost one half (48.7%) of all cases of sepsis with organ dysfunction treated in adult intensive care units. In 2023–2024, according to the system established to monitor the status of country progress towards the implementation of the AMR global action plan (the Tracking AMR Country Self-assessment Survey), 9% of countries did not yet have an IPC programme or plan. Only 39% of countries had IPC programmes fully implemented nationwide, with some being monitored for their effectiveness.
  18. Content Article
    This Toolkit is designed to equip healthcare professionals with the essential knowledge, resources, and tools to tackle the complex problems of MRSA prevention in hospital intensive care units (ICUs) and non-intensive care units (non-ICUs). The four key strategies of MRSA prevention The comprehensive unit-based safety program (CUSP) for MRSA prevention Program implementation of MRSA prevention
  19. Content Article
    Free global digital textbook. Volume 1 - Antimicrobial resistance and One Health Volume 2 - Infection prevention and control and antimicrobial stewardship Volume 3 - Sepsis and infections in surgery
  20. Content Article
    The first WISH report on tackling antimicrobial resistance (AMR) was published more than a decade ago. Section 1 of this report reviews progress on recommended actions in the five areas identified by the 2013 report. Section 2 of the report considers opportunities for action in three areas: global citizen engagement, translational science and policy and regulation, illustrated by case studies from around the world. Section 3 of the report takes stock of what has emerged from the United Nations (UN) General Assembly High-Level Meeting on tackling AMR and makes six recommendations. Recommendation 1 International organisations should put into action the 2024 UN AMR high-level meeting recommendation to establish an independent body to advise on the evidence and inform action. This panel will identify gaps in the current evidence on AMR, assess emerging and future risks of AMR, and inform cost-effective options for mitigating AMR, including global targets. Recommendation 2 Countries and international bodies should engage their citizens in tackling AMR, with clear plans to do so by 2028. Recommendation 3 Governments should give more priority to water and sanitation in addressing AMR. This includes increasing investment in water, sanitation and hygiene (WASH) to reduce infections and environmental microbe exposure, and the development of national programs to surveil antibiotic residues, resistance genes and resistant pathogens in the water supply and factory effluent. Recommendation 4 By 2027, high-income countries should commit to only prescribing antibiotics (with a few defined exceptions) when need is confirmed by a diagnostic test. Low- and middle-income countries should achieve this by 2030. Recommendation 5 By 2026, all high-income countries should have introduced pull incentives for the development of new antimicrobials, to deliver on global antibiotic priorities. Recommendation 6 Global health organisations should use the forthcoming centenary of the discovery of penicillin (2028) to accelerate progress on the AMR agenda. We have four years before the centenary of the discovery of penicillin (2028) to accelerate progress on tackling AMR, so that we can keep antibiotics working for the next 100 years.
  21. Content Article
    Antimicrobial resistance (AMR) poses an important global health challenge. Evaluating changing trends in AMR mortality across time and location is necessary to understand how this important global health threat is developing and prepares us to make informed decisions regarding interventions. This study presents the first comprehensive assessment of the global burden of AMR from 1990 to 2021, with results forecasted until 2050. The results showed a high variability of AMR burden by location and age, so it is important that interventions combine infection prevention, vaccination, minimisation of inappropriate antibiotic use in farming and humans and research into new antibiotics to mitigate the number of AMR deaths that are forecasted for 2050.
  22. Content Article
    Infection Prevention and Control (IPC) is considered to be a practical, evidence-based approach to prevent avoidable infections in healthcare settings, including those caused by antimicrobial resistant germs. In this blog, Claire Kilpatrick highlights a review article published in 2020. It outlines the approaches to prevention of surgical site infections (SSI) and adds new information on the world of global IPC, including recently launched initiatives that might impact on and support the surgical community. It also summarises some of the resources to implement the World Health Organization’s (WHO) SSI prevention guidelines. The founding member of WSIS, Joseph Solomkin, was chair of and played a key influencing role in this guideline evidence.
  23. Event
    WHO Infection Prevention and Control Global Webinar Series Each year the WHO’s World Hand Hygiene day aims to maintain a global profile on the importance of hand hygiene in health care and to ‘bring people together’ in support of hand hygiene improvement globally. On this day, everyone, in countries and health facilities, can renew their support and promote and implement strategies and innovations to improve hand hygiene practices in health care. Objectives: To promote a shared understanding of the fact that IPC education and training should be in place for all health workers by utilizing team- and task-based strategies that are participatory and include bedside and simulation training to reduce the risk of HAI and AMR. To outline the importance of campaigning for hand hygiene and WHHD 2024 resources. To outline and describe proposed WHHD 2024 activities. To stimulate engagement with the campaign on and around 5 May 2024. Register
  24. Event
    If you work in primary care or primary care research, this one-hour NIHR Evidence webinar is for you. This webinar will cover NIHR research that could help reduce antibiotic prescribing in primary care. Speakers will present actionable evidence on antibiotic stewardship, and safe and effective prescribing. Presentations will be followed by a Q&A session, giving you a unique opportunity to quiz the researchers on how this research could be implemented at your organisation and reflect on potential barriers and facilitators. The webinar will cover: making decisions about who is in most need of antibiotics if antibiotics are needed for children with chest infections how digital tools can help reduce antibiotic prescribing. Register
  25. Community Post
    NHS hospital staff spend countless hours capturing data in electronic prescribing and medicines administration systems. Yet that data remains difficult to access and use to support patient care. This is a tremendous opportunity to improve patient safety, drive efficiencies and save time for frontline staff. I have just published a post about this challenge and Triscribe's solution. I would love to hear any comments or feedback on the topic... How could we use this information better? What are hospitals already doing? Where are the gaps? Thanks
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.